论文部分内容阅读
血管生成是毛细血管从已存在的血管网络中生长出来的生理过程,可满足组织生成时的营养供给,对于肿瘤的维持或生长至关重要,因此,血管生成抑制剂被认为是癌症治疗的有效手段。血管内皮蛋白的受体酪氨酸激酶(RTK)在血管生成过程中具有重要作用,可作为抗肿瘤药作用靶点。据此,雅培
Angiogenesis is the physiological process by which capillaries grow from an existing vascular network and serves the nutrient supply at the time of tissue production and is crucial for the maintenance or growth of the tumor. Therefore, angiogenesis inhibitors are believed to be effective for cancer treatment means. Receptor tyrosine kinase (RTK) of vascular endothelial protein plays an important role in the process of angiogenesis and can be used as a target of anti-tumor drugs. Accordingly, Abbott